Long-term cohort study of women at intermediate risk of familial breast cancer: Experiences of living at risk

Psycho-Oncology

Volumn 19, Issue 4, 2010, Pages 390-398

  Bennett, P ^a   Parsons, E ^a   Brain, K ^a   Hood, K ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cancer; Distress; Genetic; Risk; Worry

Indexed keywords

ADJUSTMENT; ADULT; ANXIETY; ARTICLE; ATTITUDE TO ILLNESS; BREAST CANCER; BREAST CANCER WORRY SCALE; BREAST SELF EXAMINATION; CANCER RISK; CANCER SUSCEPTIBILITY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; EMOTIONAL STRESS; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENETIC COUNSELING; HEALTH CARE UTILIZATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PSYCHOMETRY; QUALITY OF LIFE; RISK ASSESSMENT; SELF CONCEPT;

ANXIETY; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PSYCHOLOGICAL TESTS; RISK FACTORS;

EID: 77950913712     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1588     Document Type: Article

References (35)

1. Sivell S, Iredale R, Gray J, Coles B. Cancer genetic risk assessment for individuals at risk of familial breast cancer. Cochrane Database Syst Rev 2007;(2):CD003721. (Pubitemid 351805722)
2. Foster C, Watson M, Eeles R et al. Psychosocial study collaborators. Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up. Br J Cancer 2007;96:718-724.
3. van Oostrom I, Meijers-Heijboer H, Lodder LN et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol 2003;21(20):3867-3874. (Pubitemid 46606243)
4. Brain K, Gray J, Norman P et al. Why do women attend familial breast cancer clinics? J Med Genet 2000;37:197-202.
5. Gray J, Brain K, Norman P et al. A model protocol evaluating the introduction of genetic assessment for women with a family history of breast cancer. J Med Genet 2000;37:192-196. (Pubitemid 30245913)
6. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991;48:232-242. (Pubitemid 21891587)
7. National Institute of Clinical Excellence. Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. NICE, London, 2004.
8. Hay JL, McCaul KD, Magnan RE. Does worry about breast cancer predict screening behaviors? A meta-analysis of the prospective evidence. Prev Med 2006;42:401-408.
9. van Dijk S, Timmermans DR, Meijers-Heijboer H Tibben A, van Asperen CJ, Otten W. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer. J Clin Oncol 2006;24:3672-3677. (Pubitemid 46630543)
10. van Dooren S, Rijnsburger AJ, Seynaeve C et al. Psychological distress and breast self-examination frequency in women at increased risk for hereditary or familial breast cancer. Community Genet 2003;6:235-241. (Pubitemid 39179230)
11. Brain K, Norman P, Gray J, Mansel R. Anxiety and adherence to breast self-examination in women with a family history of breast cancer. Psychosom Med 1999;61:181-187. (Pubitemid 29168648)
12. Bennett P, Wilkinson C, Turner J, Griffin G, France, Brain K, Gray J. The impact of breast cancer genetic risk assessment on intentions to perform cancer surveillance behaviors. J Genet Couns 2007;16:617-623. (Pubitemid 350163647)
13. Humphrey LL, Helfand M, Chan BKS, Woolf SH. Breast cancer screening: a summary of the evidence for the US preventive services task force. Ann Intern Med 2002;137:347-360. (Pubitemid 34977137)
14. Kosters JP, Gotzsche PC. Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database Syst Rev 2003;(2):CD003373.
15. Lloyd S, Watson M, Waites B et al. Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling. Br J Cancer 1996;74:482-487. (Pubitemid 26254584)
16. Hopwood P, Shenton A, Lalloo F, Evans DG, Howell A. Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer. J Med Genet 2001;38:139.
17. Miller SM, Shoda Y, Hurley K. Applying cognitive social theory to health protective behavior: breast self-examination in cancer screening. Psychol Bull 1996;119:70-94.
18. Abela JRZ, Seligman MEP. The hopelessness theory of depression: a test of the diathesis-stress component in the interpersonal and achievement domains. Cog Ther Res 2000;23:361-378.
19. Abramson LY, Alloy LB, Hankin BL. Cognitive vulnerability - stress models of depression in a self-regulatory and psychobiological context. In Handbook of Depression, Gotlib IH, Hammen CL (eds). Guilford: New York, 2002.
20. Gramling R, Anthony D, Lowery J et al. Association between screening family medical history in general medical care and lower burden of cancer worry among women with a close family history of breast cancer. Genet Med 2005;7:640-645.
21. Loescher LJ. Cancer worry in women with hereditary risk factors for breast cancer. Oncol Nurs Forum 2003;30:767-772.
22. Wylie JE, Smith KR, Botkin JR. Effects of spouses on distress experienced by BRCA1 mutation carriers over time. Am J Genet C Semin Med Genet 2003;119C:35-44.
23. van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ et al. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study. Clin Genet 2007;71:35-42. (Pubitemid 44929338)
24. Bennett P, Wilkinson C, Turner J, Tudor Edwards R, France D, Gray J. Factors associated with intrusive cancer-related worries in women undergoing cancer genetic risk assessment. Familial Cancer. DOI: 10.1007/s10689-008-9221-9.
25. Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med 1979;41:209-218. (Pubitemid 9219271)
26. Horowitz MJ. Treatment of Stress Response Syndromes. American Psychiatric Publishing: Arlington, VA, 2003.
27. Lerman C, Trock B, Rimer BK, Jepson C, Brody D, Boyce A. Psychological side effects of breast cancer screening. Health Psychol 1991;10:259-267.
28. Broadhead WE, Gehlbach SH, De Gruy FV, Kaplan BH. The Duke-UNC functional social support questionnaire measurement of social support in family medicine patients. Med Care 1988;26:709-723.
29. The EuroQoL Group. EuroQoL-a new facility for the measurement of health related quality of life. Health Policy 1990;16:199-208.
30. Cottin V, Arpin D, Lasset C et al. Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole. Ann Oncol 1999;10:809-815. (Pubitemid 29367998)
31. Zwar N, Henderson J, Britt H, McGeechan K, Yeo G. Influencing antibiotic prescribing by prescriber feedback and management guidelines: a 5-year follow-up. Fam Pract 2002;19:12-17. (Pubitemid 34173269)
32. Braithwaite D, Emery J, Walter F, Prevost AT, Sutton S. Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. Fam Cancer 2006;5:61-75. (Pubitemid 43384321)
33. Bennett P, Wilkinson C, Turner J et al. Psychological factors associated with emotional responses to receiving genetic risk information. J Genet Counsel 2008;17:234-241.
34. Bennett P, Phelps C, Brain K, Hood K, Gray J. A randomised controlled trial of a brief self-help coping intervention designed to reduce distress when awaiting genetic risk information. J Psychosom Res 2008;63:59-64. (Pubitemid 46935797)
35. Appleton S, Watson M, Rush R et al. A randomised controlled trial of a psychoeducational intervention for women at increased risk of breast cancer. Br J Cancer 2004;90:41-47. (Pubitemid 38174936)